APA (7th ed.) Citation

N, L., Y, C., J, L., S, L., Y, T., J, H., . . . H, Z. (2025). RBM7 suppresses mitochondrial dysfunction and ferroptosis by destabilizing FBXL16 mRNA to enhance Temozolomide resistance in glioblastoma. Molecular genetics and genomics : MGG, 301(1), 1. https://doi.org/10.1007/s00438-025-02313-y

Chicago Style (17th ed.) Citation

N, Liu, Cui Y, Li J, Li S, Tu Y, Huo J, Zhang T, and Zhen H. "RBM7 Suppresses Mitochondrial Dysfunction and Ferroptosis by Destabilizing FBXL16 MRNA to Enhance Temozolomide Resistance in Glioblastoma." Molecular Genetics and Genomics : MGG 301, no. 1 (2025): 1. https://doi.org/10.1007/s00438-025-02313-y.

MLA (9th ed.) Citation

N, Liu, et al. "RBM7 Suppresses Mitochondrial Dysfunction and Ferroptosis by Destabilizing FBXL16 MRNA to Enhance Temozolomide Resistance in Glioblastoma." Molecular Genetics and Genomics : MGG, vol. 301, no. 1, 2025, p. 1, https://doi.org/10.1007/s00438-025-02313-y.